CAPITAL INTERNATIONAL LTD /CA/
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1065350
LOS ANGELES, CA
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$42,811,575
-$535,081 QoQ
Shares Held
95,874
+0.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $119,458,337 across 7 Biotechnology names. VRTX ranks #1 (35.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
95,874 | $42,811,575 | |
| 2 | RPRX |
Royalty Pharma plc
|
570,577 | $27,370,578 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
76,515 | $22,722,659 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,610 | $10,515,630 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
29,078 | $9,621,037 | |
| 6 | ASND |
Ascendis Pharma A/S
|
16,394 | $3,749,799 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
56,066 | $2,667,059 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $42,811,575 | 95,874 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $43,346,656 | 95,612 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $47,500,840 | 121,287 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $56,810,636 | 127,607 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $54,564,551 | 112,546 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $44,526,941 | 110,571 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $46,324,293 | 99,605 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $47,092,767 | 100,471 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $41,615,403 | 99,556 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $34,535,195 | 84,876 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $28,340,462 | 81,499 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $28,237,258 | 80,240 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,964,474 | 69,713 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $18,902,094 | 65,455 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $20,513,909 | 70,850 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $17,856,186 | 63,367 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $16,507,918 | 63,256 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $18,356,583 | 83,591 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,342,141 | 73,555 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,345,825 | 86,028 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,166,272 | 79,884 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $19,181,118 | 81,159 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $22,381,870 | 82,250 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $19,168,878 | 66,029 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,996,798 | 63,025 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||